Rare diseases
Investigational molecules
Locations
2445 Technology Forest Boulevard Suite 1100, 77381-5261, United States
Research activity is centered on hypertrophic cardiomyopathy, with attention to both obstructive and non-obstructive forms. The clinical focus includes symptom burden, functional limitation, and disease-related impairment in people living with this cardiac muscle disorder.
The sponsor’s interest in this area reflects a focus on cardiology and the management of structural heart disease.
Lexicon Pharmaceuticals Inc. runs clinical trials in conditions such as Hypertrophic cardiomyopathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
